An expert system is a computer program that uses specialized knowledge in a particular domain to make decisions, predictions, or recommendations. It relies solely on artificial intelligence techniques, such as rules-based algorithms and artificial neural networks, to do its job. Expert systems are a type of intelligent software that use knowledge-based systems to present human-like expertise and reasoning. Expert systems use data and facts from a variety of sources to evaluate various situations and events. This input is used to provide detailed information and advice for decision making or problem solving. Expert systems have excellent reasoning abilities and can be programmed to reason in the same manner as a human expert. In addition to data and facts, expert systems can also use heuristics, or rules of thumb, to make decisions and recommend solutions. Heuristics enable expert systems to evaluate multiple possibilities to arrive at the best course of action. Through the use of data, facts, and heuristics, expert systems can make accurate and reliable decisions quickly and efficiently. For example, a medical expert system may use data from a patient’s medical history, facts from medical research, and heuristic-based analysis to diagnose a medical condition. It may also make recommendations on how to treat the condition. The same principles can be applied to any domain where expert knowledge is necessary to make decisions. Expert systems offer a range of advantages, including faster decision making, improved accuracy and reliability, improved ability to handle large amounts of data, and the ability to share expertise quickly and efficiently. Also, expert systems are relatively easy to develop and maintain. In conclusion, expert systems are a type of computer program that relies on artificial intelligence techniques to provide expert advice and reasoning for decision making. They use data, facts, and heuristics to make accurate and reliable decisions quickly and efficiently. Expert systems offer a range of advantages, including faster decision making and improved accuracy and reliability.
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States